Contacts
ITA | ENG
Facebook icon to access the profile of Eurofins Genoma, a center of excellence for genetic and cytogenetic tests. LinkedIn icon to access the professional profile of Eurofins Genoma, a reference point for genetic and cytogenetic tests.

WHO WE ARE

The Italian and European benchmark for molecular diagnosis.

Since 1997, it has primarily operated as a diagnostic partner for:

  • genetic analyses
  • cytogenetic analyses
  • infectious disease analyses
CONTACT US

EUROFINS GENOMA GROUP IS COMPOSED OF

5 laboratories and several collection points

Roma2

Milano1

Firenze1

Modena1

The laboratories, modern and equipped with the most advanced instruments and technologies, span over a total area of over 7.000 square meters, ensuring high-quality standards.

PIONEERS IN GENETICS

EXPERIENCE

We receive biological samples for analysis from over 2.000 healthcare facilities and hospitals, both in Italy and abroad, on a daily basis. Our internal organization is structured to support significant workloads.

Eurofins Genoma's activity extends throughout the national territory and also abroad, in Europe, the United States, Asia, and the Middle East, providing specialized diagnostic support for healthcare facilities, public and private, analysis laboratories, nursing homes, hospitals, private clinics, medical outpatient clinics, assisted reproduction centers, and specialist doctors in various disciplines.

Annual, ever-growing number of genetic tests performed.

220.000

ADVANCED DIAGNOSTICS

ANALYTICAL COMPLETENESS

Eurofins Genoma offers a diverse range of services among the most comprehensive in the national and international territories, allowing patients and their physicians to access innovative diagnostic solutions for any clinical need.

3.000

genetic tests in portfolio

6 areas of expertise

for customized requests

Illustration of a microscope representing Eurofins Genoma's collaboration with 2070 laboratories, highlighting their role as a reference point for molecular diagnosis.

Partner companies

+40.000

Illustration of a magnifying glass with a DNA double helix, representing the numerous analyses performed by Eurofins Genoma, highlighting their expertise in molecular diagnosis.

Analyses performed each year:

+220.000

Illustration of a document with a magnifying glass, symbolizing the portfolio of analyses performed by Eurofins Genoma.

Analyses portfolio:

+3.000

Illustration of a pregnant woman, representing the numerous annual NIPT analyses performed by Eurofins Genoma, highlighting their expertise in the field of prenatal diagnosis.

NIPT
annual analyses:

+50.000

Illustration of a globe, representing the global presence of Eurofins Genoma in 42 countries, highlighting their international reach in molecular diagnostics.

Number of countries where we operate:

65

Starting from March 2024, Eurofins Genoma expands its specialization to include routine diagnosis with specialized sectors: microbiology and virology, toxicology, cytology, histology.

DRIVING INNOVATION

OUR MISSION

Eurofins Genoma aims to promote and enhance existing diagnostic processes by developing new products, processes, and services in the biotechnology sector, contributing to the transition from curative to predictive medicine.

ACT TODAY, THINK TOMORROW

OUR FILOSOFY

Update

Anticipate

Progress

Operate in the present, always looking forward.

With this important premise, our choice has been, and still is, to integrate the most modern management efficiency and continuous training of all staff, with a continuous evolution of technological equipment and diagnostic methods, in line with the highest quality standards.

Genoma is part of the Eurofins Group since 2017, leading provider of analytical services with an international network of over 900 laboratories worldwide.

CONTACT US

TEAM

The professionals who make up the Eurofins Genoma Team have been working in the field of genetics for over 20 years.

+200 professionals

including geneticists, molecular biologists, bioinformaticians, and laboratory technicians, operate within a highly technical and scientific facility, focusing on cytogenetic and molecular diagnostics for both clinical applications and research.

Collaborations with scientific networks and research projects confer international prestige to the Eurofins Genoma Group.

Eurofins Genoma relies on the experience and professionalism of a highly skilled Scientific Board.

QUALITY SYSTEM

For us, quality is more than just a result: it's a company value.

The quality system of Eurofins Genoma laboratory is a well-integrated and consolidated process in all company procedures, aimed at ensuring maximum satisfaction of our stakeholders.

Eurofins Genoma Laboratory is certified UNI EN ISO 9001:2015 and regularly participates in external quality controls entrusted to nationally and internationally recognized institutions.

Eurofins Genoma Laboratory has also obtained, for its Milan headquarters, accreditation from the Italian accreditation body ACCREDIA for the UNI CEI EN ISO/IEC 17025:2018 scheme for Forensic Genetics testing, further demonstrating that the laboratory ensures the highest quality standard.

Eurofins Genoma Laboratory has been accredited as a SMeL (Laboratory Medicine Services) by the Lombardy Region since 2018. Accreditation to the regional health service is a fundamental step towards improving the quality of care and ensures the protection of citizens through the verification of requirements on organizational appropriateness, prescribing appropriateness, and the quality of analytical production.

Like every accredited SMeL, Eurofins Genoma utilizes Internal Quality Control (IQC) systems and implements External Quality Assessment (EQA) programs.

The entire analytical process is subject to constant control by specialized operators and internal procedures that allow constant traceability of the analyzed samples.

Thanks to the aforementioned organizational model, Eurofins Genoma is continuously improving to always provide a high-profile service.

DISCOVER MORE

SUPPORTING RESEARCH

FOUNDED PROJECTS

done

“Ge.Noma Export (GE.N.E.)” PROJECT

done

“LIFE2020 ONCONEXT” PROJECT